Expression of AEG-1 and p53 and their clinicopathological significance in malignant lesions of renal cell carcinomas: A microarray study

Polish Journal of Pathology

Volumn 64, Issue 1, 2013, Pages 28-32

  Erdem, Havva ^a   Oktay, Murat ^a   Yildirim, Umran ^b   Uzunlar, Ali Kemal ^a   Kayikci, M Ali ^a  

^a DUZCE UNIVERSITY   (Turkey)

^b FATIH UNIVERSITY   (Turkey)

Author keywords

AEG 1; p53; Prognostic parameters; Renal cell carcinomas

Indexed keywords

CELL ADHESION MOLECULE; MTDH PROTEIN, HUMAN; PROTEIN P53;

ADULT; AGED; ARTICLE; CELL NUCLEUS; DNA MICROARRAY; FEMALE; GENE EXPRESSION PROFILING; HUMAN; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY CARCINOMA; KIDNEY TUMOR; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; CELL ADHESION MOLECULES; CELL NUCLEUS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; KIDNEY; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROGNOSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84876960888     PISSN: 12339687     EISSN: None     Source Type: Journal    
DOI: 10.5114/PJP.2013.34600     Document Type: Article

References (31)

1. Nelson EC, Evans CP, Lara PN Jr. Renal cell carcinoma: current status and emerging therapies. Cancer Treat Rev 2007; 33: 299-313.
2. Curti BD. Renal cell carcinoma. JAMA 2004; 292: 97-100.
3. Su ZZ, Kang DC, Chen YL. Identification and cloning of human astrocyte genes displaying elevated expression after infection with HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid subtraction hybridization, RaSH. Oncogene 2002; 21: 3592-3602.
4. Britt DE, Yang DF, Yang DQ, et al. Identification of a novel protein, LYRIC, localized to tight junctions of polarized epithelial cells. Exp Cell Res 2004; 300: 134-148.
5. Sutherland HG, Lam YW, Briers S, et al. 3D3/lyric: a novel transmembrane protein of the endoplasmic reticulum and nuclear envelope, Which is also present in the nucleolus. Exp Cell Res 2004; 294: 94-105.
6. Kang DC, Su ZZ, Sarkar D, et al. Cloning and characterization of HIV-1-inducible astrocyte elevated gene-1, AEG-1. Gene 2005; 353: 8-15.
7. Kim DH, Mohapatra G, Bollen A, et al. Chromosomal abnormalities in glioblastoma multiforme tumors and glioma cell lines detected by comparative genomic hybridization. Int J Cancer 1995; 60: 812-819.
8. Poon TC, Wong N, Lai PB, et al. A tumor progression model for hepatocellular carcinoma: bioinformatic analysis of genomic data. Gastroenterology 2006; 131: 1262-1270.
9. Wang Y, Klijn JG, Zhang Y, et al. Geneexpression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 2005; 365: 671-679.
10. van't Veer LJ, Dai H, van de Vijver MJ, et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002; 415: 530-536.
11. van de Vijver MJ, He YD, van't Veer LJ, et al. A gene expression signature as a predictor of survival in breast cancer. N Engl J Med 2002; 347: 1999-2009.
12. Liu X, Zhang N, Li X, et al. Identification of novel variants of metadherin in breast cancer. PLoS One 2011, 6:e17582.
13. Vousden KH, Lu X. Live or let die: the cell's response to p53. Nat Rev Cancer 2002; 2: 594-604.
14. Chowdhury S, Matrana MR, Tsang C, et al. Systemic therapy for metastatic non-clear-cell renal cell carcinoma: recent progress and future directions. Hematol Oncol Clin North Am 2011; 25: 853-869.
15. Chen W, Ke Z, Shi H, et al. Overexpression of AEG-1 in renal cell carcinoma and its correlation with tumor nuclear grade and progression. Neoplasma 2010; 57: 522-529.
16. Li J, Zhang N, Song LB, et al. Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival. Clin Cancer Res 2008; 14: 3319-3326.
17. Yu C, Chen K, Zheng H, et al. Overexpression of astrocyte elevated gene-1 (AEG-1) is associated with esophageal squamous cell carcinoma (ESCC) progression and pathogenesis. Carcinogenesis 2009; 30: 894-901.
18. Song L, Li W, Zhang H, et al. Over-expression of AEG-1 significantly associates with tumour aggressiveness and poor prognosis in human nonsmall cell lung cancer. J Pathol 2009; 219: 317-326.
19. Fuhrman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982; 6: 655-663.
20. Thirkettle HJ, Girling J, Warren AY, et al. LYRIC/AEG-1 is targeted to different subcellular compartments by ubiquitinylation and intrinsic nuclear localization signals. Clin Cancer Res 2009; 15: 3003-3013.
21. Lee LS, Yuen JS, Sim HG. Renal cell carcinoma in young patients is associated with poorer prognosis. Ann Acad Med Singapore 2011; 40: 401-406.
22. Liao WT, Guo L, Zhong Y, et al. Astrocyte elevated gene-1 (AEG-1) is a marker for aggressive salivary gland carcinoma. J Transl Med 2011; 9: 205.
23. Sherr CJ, Weber JD. The ARF/p53 pathway. Curr Opin Genet Dev 2000; 10: 94-99.
24. Girgin C, Tarhan H, Hekimgil M, et al. p53 mutations and other prognostic factors of renal cell carcinoma. Urol Int 2001; 66: 78-83.
25. Uchida T, Gao JP, Wang C, et al. Clinical significance of p53, mdm2, and bcl-2 proteins in renal cell carcinoma. Urology 2002; 59: 615-620.
26. Luo J, Manning BD, Cantley LC. Targeting the PI3K-Akt pathway in human cancer: rationale and promise. Cancer Cell 2003; 4: 257-262.
27. Carroll PE, Okuda M, Horn HF, et al. Centrosome hyperamplification in human cancer: chromosome instability induced by p53mutation and/or Mdm2 overexpression. Oncogene 1999; 8: 1935-1944.
28. Sejima T, Isoyama T, Miyagawa I. Alteration of apoptotic regulatory molecules expression during carcinogenesis and tumor progression of renal cell carcinoma. Int J Urol 2003; 10: 476-484.
29. Baytekin F, Tuna B, Mungan U, et al. Significance of P-glycoprotein, p53, and survivin expression in renal cell carcinoma. Urol Oncol 2011; 29: 502-507.
30. Cho DS, Joo HJ, Oh DK, et al. Cyclooxygenase-2 and p53 expression as prognostic indicators in conventional renal cell carcinoma. Yonsei Med J 2005; 46: 133-140.
31. Hodorova I, Solar P, Mihalik J, et al. Investigation of tumour supressor protein p53 in renal cell carcinoma patients from Slovakia. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2012 Jun 1. doi: 10.5507/bp.2012.035.